Category: Regulations
-
Precision Cancer Drug Shown Effective in Adults, Children
Results from 3 clinical trials show most cancer patients given an experimental drug that directly addresses a specific genetic mutation respond to the treatments, despite their cancers occurring in a variety of organs.
-
Trial Shows Treatment Desensitizes Peanut Allergies
A large-scale clinical trial shows a preventive treatment desensitizes peanut allergies in children, with most participants able to tolerate substantial amounts of peanut proteins after 1 year.
-
NIH Exec: Research Offers Opioid Crisis Solutions
The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths.
-
FDA Clears First Blood Test for Concussions
The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury.
-
Infographic – Software Security Risks at Record Level
This weekend’s infographic is from our friends at Statista who published a recent chart showing the almost constant rise in security risks since 2010 due to software, recorded by Hasso-Plattner-Institute in Germany.
-
Low Carb Diet, Biomarker Tracking Help Reverse Diabetes
A combination of low-carbohydrate diet, with close monitoring of health indicators and coaching via a mobile app are shown in a clinical trial to reverse type 2 diabetes, including reductions in medication and insulin therapy.
-
FDA Approves Wearable Epilepsy Seizure Detector
The U.S. Food and Drug Administration approved a device worn like a wristwatch that uses a machine-learning algorithm to detect convulsive seizures in people with epilepsy.
-
Workplace Health And Safety – Why It’s More Important Than Ever
Today, businesses are judged heavily on their ethics, so it’s important that your business is seen as not only protecting your employees, customers and clients.
-
Engineered T-Cells Show Extended Leukemia Remission
A clinical trial shows a patient’s immune system cells, modified to add cancer-fighting proteins, can extend high remission among children with a type of leukemia for as long as 12 months, but also with high rates of adverse effects.
-
Report: 19 New Precision Medicines Approved in 2017
A report on Food and Drug Administration approvals of new therapies says the agency is accelerating its reviews of treatments designed to address the specific molecular composition of individuals.